The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
from NDTV News - Special https://ift.tt/2EntxSq
via
Subscribe to:
Post Comments (Atom)
Rs 5 Lakh Lump Sum vs Rs 5,000 Monthly SIP: Which Creates More Wealth?
Lump sum and Systematic Investment Plan (SIP) are two popular ways of investing in mutual funds. While lump sum involves investing a large a...
-
Officers yelled at Richard Sanchez to drop his gun - and eventually, he did. He started to walk toward law enforcement, out of a house a rel...
-
Defending champions Mumbai Indians sent their fans into a frenzy when they posted a short video of skipper Rohit Sharma, batsman Kieron Poll...
-
Classic Legends has released a latest teaser video giving a glimpse of the upcoming Yezdi motorcycle which will be launched on January 13, 2...
No comments:
Post a Comment